Mucosal cancer-associated microbes and anastomotic leakage after resection of colorectal carcinoma
Copyright © 2019 Elsevier Ltd. All rights reserved..
BACKGROUND: Clinical and experimental evidence suggests that colorectal mucosal microbiota changes during colorectal carcinogenesis and may impair colorectal anastomotic wound healing. Thus, we hypothesized that amounts of colorectal cancer-associated microbes in colorectal tissue might be associated with anastomotic leakage after resection for colorectal carcinoma.
METHODS: We analyzed 256 fresh frozen tissues of colorectal cancer from patients who underwent elective colorectal resection and anastomosis. Amounts of colorectal cancer-associated microbes, including Fusobacterium nucleatum, Escherichia coli possessing the polyketide synthase (pks) gene cluster, Enterococcus faecalis, and Bifidobacterium genus, in colorectal cancer tissues were measured by quantitative polymerase chain reaction assay; we equally dichotomized positive cases (high versus low). Multivariable logistic regression analysis was conducted to assess associations of these microbes with anastomotic leakage, adjusting for patient and tumor characteristics, and surgery-related factors.
RESULTS: Fusobacterium nucleatum, pks-positive Escherichia coli, Enterococcus faecalis, and Bifidobacterium genus were detected in colorectal carcinoma tissue in 140 (54%), 94 (36%), 193 (75%), and 89 (35%) of 256 cases, respectively. Compared with Bifidobacterium genus-negative cases, Bifidobacterium genus-high cases were associated with an increased risk of anastomotic leakage (multivariable odds ratio, 3.96; 95% confidence interval, 1.50 to 10.51; Ptrend = 0.004). The association of Fusobacterium nucleatum, pks-positive Escherichia coli, or Enterococcus faecalis with anastomotic leakage was not statistically significant.
CONCLUSIONS: The amount of Bifidobacterium genus in colorectal tissue is associated with an increased risk of anastomotic leakage after resection for colorectal cancer. These findings need to be validated to target gastrointestinal microflora for the prevention of anastomotic leakage after colorectal resection.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
---|---|
Enthalten in: |
Surgical oncology - 32(2020) vom: 01. März, Seite 63-68 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mima, Kosuke [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 30.10.2020 Date Revised 03.04.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.suronc.2019.11.005 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM303683465 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM303683465 | ||
003 | DE-627 | ||
005 | 20231225113341.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.suronc.2019.11.005 |2 doi | |
028 | 5 | 2 | |a pubmed24n1012.xml |
035 | |a (DE-627)NLM303683465 | ||
035 | |a (NLM)31765952 | ||
035 | |a (PII)S0960-7404(19)30046-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mima, Kosuke |e verfasserin |4 aut | |
245 | 1 | 0 | |a Mucosal cancer-associated microbes and anastomotic leakage after resection of colorectal carcinoma |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.10.2020 | ||
500 | |a Date Revised 03.04.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2019 Elsevier Ltd. All rights reserved. | ||
520 | |a BACKGROUND: Clinical and experimental evidence suggests that colorectal mucosal microbiota changes during colorectal carcinogenesis and may impair colorectal anastomotic wound healing. Thus, we hypothesized that amounts of colorectal cancer-associated microbes in colorectal tissue might be associated with anastomotic leakage after resection for colorectal carcinoma | ||
520 | |a METHODS: We analyzed 256 fresh frozen tissues of colorectal cancer from patients who underwent elective colorectal resection and anastomosis. Amounts of colorectal cancer-associated microbes, including Fusobacterium nucleatum, Escherichia coli possessing the polyketide synthase (pks) gene cluster, Enterococcus faecalis, and Bifidobacterium genus, in colorectal cancer tissues were measured by quantitative polymerase chain reaction assay; we equally dichotomized positive cases (high versus low). Multivariable logistic regression analysis was conducted to assess associations of these microbes with anastomotic leakage, adjusting for patient and tumor characteristics, and surgery-related factors | ||
520 | |a RESULTS: Fusobacterium nucleatum, pks-positive Escherichia coli, Enterococcus faecalis, and Bifidobacterium genus were detected in colorectal carcinoma tissue in 140 (54%), 94 (36%), 193 (75%), and 89 (35%) of 256 cases, respectively. Compared with Bifidobacterium genus-negative cases, Bifidobacterium genus-high cases were associated with an increased risk of anastomotic leakage (multivariable odds ratio, 3.96; 95% confidence interval, 1.50 to 10.51; Ptrend = 0.004). The association of Fusobacterium nucleatum, pks-positive Escherichia coli, or Enterococcus faecalis with anastomotic leakage was not statistically significant | ||
520 | |a CONCLUSIONS: The amount of Bifidobacterium genus in colorectal tissue is associated with an increased risk of anastomotic leakage after resection for colorectal cancer. These findings need to be validated to target gastrointestinal microflora for the prevention of anastomotic leakage after colorectal resection | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Bacteria | |
650 | 4 | |a Complication | |
650 | 4 | |a Surgery | |
700 | 1 | |a Sakamoto, Yuki |e verfasserin |4 aut | |
700 | 1 | |a Kosumi, Keisuke |e verfasserin |4 aut | |
700 | 1 | |a Ogata, Yoko |e verfasserin |4 aut | |
700 | 1 | |a Miyake, Keisuke |e verfasserin |4 aut | |
700 | 1 | |a Hiyoshi, Yukiharu |e verfasserin |4 aut | |
700 | 1 | |a Ishimoto, Takatsugu |e verfasserin |4 aut | |
700 | 1 | |a Iwatsuki, Masaaki |e verfasserin |4 aut | |
700 | 1 | |a Baba, Yoshifumi |e verfasserin |4 aut | |
700 | 1 | |a Iwagami, Shiro |e verfasserin |4 aut | |
700 | 1 | |a Miyamoto, Yuji |e verfasserin |4 aut | |
700 | 1 | |a Yoshida, Naoya |e verfasserin |4 aut | |
700 | 1 | |a Ogino, Shuji |e verfasserin |4 aut | |
700 | 1 | |a Baba, Hideo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Surgical oncology |d 1997 |g 32(2020) vom: 01. März, Seite 63-68 |w (DE-627)NLM012658448 |x 1879-3320 |7 nnns |
773 | 1 | 8 | |g volume:32 |g year:2020 |g day:01 |g month:03 |g pages:63-68 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.suronc.2019.11.005 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 32 |j 2020 |b 01 |c 03 |h 63-68 |